Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis
Abstract Background Skin diseases are a category of chronic conditions that often impact patients’ appearance, potentially leading to psychological issues, including sexual dysfunction. The present study is an attempt to determine the global prevalence of female sexual dysfunction (FSD) in women wit...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Women's Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12905-025-03625-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850072220402974720 |
|---|---|
| author | Pegah Heidarian Amir Jalali Mohammadrasool Ghasemianrad Romina Jalali Ebrahim Ezzati |
| author_facet | Pegah Heidarian Amir Jalali Mohammadrasool Ghasemianrad Romina Jalali Ebrahim Ezzati |
| author_sort | Pegah Heidarian |
| collection | DOAJ |
| description | Abstract Background Skin diseases are a category of chronic conditions that often impact patients’ appearance, potentially leading to psychological issues, including sexual dysfunction. The present study is an attempt to determine the global prevalence of female sexual dysfunction (FSD) in women with skin diseases. Methods For this systematic review and meta-analysis, databases including PubMed, Web of Science, Scopus, Science Direct, Embase, and Google Scholar were systematically searched for relevant studies. All published research up to April 2024 imported into EndNote for further analysis. A random-effects model was applied for the analysis, and the I² statistic was used to assess study heterogeneity. Results Analysis of 24 studies (45 datasets) indicated that the overall prevalence of FSD in women with skin diseases was estimated at 61.3% (95% CI: 53.9–68.2%). Additionally, subgroup analysis based on skin disease type revealed an FSD prevalence of 69.8% (95% CI: 56.7–80.2%) in women with vitiligo, 59.2% (95% CI: 49.1–68.5%) in those with psoriasis, and 56.5% (95% CI: 47.8–64.8%) in women with hidradenitis suppurativa. Conclusion There was a high prevalence of FSD in women with skin diseases. There is a need for policy makers and healthcare providers to prioritize the well-being of these patients. |
| format | Article |
| id | doaj-art-11ddc57427da4668a2ead3e630186eff |
| institution | DOAJ |
| issn | 1472-6874 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Women's Health |
| spelling | doaj-art-11ddc57427da4668a2ead3e630186eff2025-08-20T02:47:07ZengBMCBMC Women's Health1472-68742025-03-0125111410.1186/s12905-025-03625-2Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysisPegah Heidarian0Amir Jalali1Mohammadrasool Ghasemianrad2Romina Jalali3Ebrahim Ezzati4Student Research Committee, Kermanshah University of Medical SciencesSubstance Abuse Prevention Research Center, Research Institute for Health, Kermanshah University of Medical SciencesStudent Research Committee, Kermanshah University of Medical SciencesSleep Disorder Research Center, Kermanshah University of Medical SciencesDepartment of Anaesthesiology, School of Paramedical, Kermanshah University of Medical SciencesAbstract Background Skin diseases are a category of chronic conditions that often impact patients’ appearance, potentially leading to psychological issues, including sexual dysfunction. The present study is an attempt to determine the global prevalence of female sexual dysfunction (FSD) in women with skin diseases. Methods For this systematic review and meta-analysis, databases including PubMed, Web of Science, Scopus, Science Direct, Embase, and Google Scholar were systematically searched for relevant studies. All published research up to April 2024 imported into EndNote for further analysis. A random-effects model was applied for the analysis, and the I² statistic was used to assess study heterogeneity. Results Analysis of 24 studies (45 datasets) indicated that the overall prevalence of FSD in women with skin diseases was estimated at 61.3% (95% CI: 53.9–68.2%). Additionally, subgroup analysis based on skin disease type revealed an FSD prevalence of 69.8% (95% CI: 56.7–80.2%) in women with vitiligo, 59.2% (95% CI: 49.1–68.5%) in those with psoriasis, and 56.5% (95% CI: 47.8–64.8%) in women with hidradenitis suppurativa. Conclusion There was a high prevalence of FSD in women with skin diseases. There is a need for policy makers and healthcare providers to prioritize the well-being of these patients.https://doi.org/10.1186/s12905-025-03625-2PrevalenceSexual dysfunctionFSDSkin diseasesMeta-analysisSystematic review |
| spellingShingle | Pegah Heidarian Amir Jalali Mohammadrasool Ghasemianrad Romina Jalali Ebrahim Ezzati Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis BMC Women's Health Prevalence Sexual dysfunction FSD Skin diseases Meta-analysis Systematic review |
| title | Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis |
| title_full | Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis |
| title_fullStr | Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis |
| title_full_unstemmed | Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis |
| title_short | Global prevalence of sexual dysfunction in women with skin diseases: a systematic review and meta-analysis |
| title_sort | global prevalence of sexual dysfunction in women with skin diseases a systematic review and meta analysis |
| topic | Prevalence Sexual dysfunction FSD Skin diseases Meta-analysis Systematic review |
| url | https://doi.org/10.1186/s12905-025-03625-2 |
| work_keys_str_mv | AT pegahheidarian globalprevalenceofsexualdysfunctioninwomenwithskindiseasesasystematicreviewandmetaanalysis AT amirjalali globalprevalenceofsexualdysfunctioninwomenwithskindiseasesasystematicreviewandmetaanalysis AT mohammadrasoolghasemianrad globalprevalenceofsexualdysfunctioninwomenwithskindiseasesasystematicreviewandmetaanalysis AT rominajalali globalprevalenceofsexualdysfunctioninwomenwithskindiseasesasystematicreviewandmetaanalysis AT ebrahimezzati globalprevalenceofsexualdysfunctioninwomenwithskindiseasesasystematicreviewandmetaanalysis |